Hyperthermic vs normothermic mitomycin C for intermediate-risk NMIBC: a real-world retrospective cohort study. Arch Ital Urol Androl [Internet]. 2025 Nov. 5 [cited 2026 Jun. 13];97(4). Available from: https://www.pagepressjournals.org/aiua/article/view/14167